Montelukast Prescribing at THE ORCHARD PARTNERSHIP
Cromoglycate, leukotriene and phosphodesterase type-4 inhib | Respiratory System
Items (12m)
1,210
Total Quantity
33.0K
NHS Cost
£1.6K
vs National Avg
+76.7%
THE ORCHARD PARTNERSHIP prescribed 1,210 items of Montelukast over the last 12 months at a cost of £1,629 to the NHS. This is 76.7% above the national average prescribing rate. Montelukast is classified under Cromoglycate, leukotriene and phosphodesterase type-4 inhib in the BNF.
Monthly Prescribing Trend
Jul 2026
112
Jul 2026
90
Jul 2026
95
Jul 2026
114
Jul 2026
105
Jul 2026
104
Jul 2026
89
Jul 2026
122
Jul 2026
100
Jul 2026
84
Jul 2026
98
Jul 2026
97
Prescribing Details
| Total Items | 1,210 |
|---|---|
| Total Quantity | 33,004 |
| Total NHS Cost | £1,629 |
| Presentations | 4 different forms |
| vs National Average | +76.7% |
Montelukast Prescribing Comparison
| This practice | 1,210 items |
|---|---|
| National average per practice | 685 items |
| Difference | +76.7% vs national average |
Explore More
Data sourced from NHSBSA English Prescribing Dataset, CQC, and GP Patient Survey. Prescribing data does not indicate quality of care. Higher prescribing rates may reflect patient demographics. Always consult your GP for medical advice.